click the link below for the full book page:
https://slide.softebook.net/isuu/B0DST7WDZZ/THERAPEUTIC-REVOLUTION-to-defeat-the-inevitable-and-make-you-healthier-again
The exponential increase in the number of inquiries I have been receiving about Ozempic, Mounjaro, and other GLP-1 receptor agonists (GLP-1 RA) formulations, encouraged me to write this book, to provide insights into the beneficial effects, side effects and potential risks of these innovative molecules.When chronic degenerative diseases progress despite efforts to follow the principles extensively discussed in my previous book, The Healthspan Code, this new class of molecules could represent a possible ally. They have shown significant potential to act as a powerful ally to The Healthspan Code, temporarily halting the progression toward the “invitable”and offering another opportunity to recommit to the Healthspan pillars. These principles emphasize an ecosystem-based approach, where no single solution or magic remedy is sufficient on its own.It is crucial, therefore, to focus not only on curing diseases but also on their prevention, not just to avert the progression of risk factors toward the development of chronic degenerative diseases, but also to prevent disease recurrence after an initially successful cure, such as an islet cell transplant for people with diabetes.Recent findings highlight the wide-ranging benefits of GLP-1 RA, from preventing and slowing disease progression to mitigating risks associated with insulin resistance, excess weight, diabetes, cardiovascular and kidney diseases, neurodegenerative and autoimmune disorders, chronic inflammation, osteoarticular conditions, and even viral illnesses like COVID-19. Notably, emerging data revealed that GLP-1 receptor